25 Years Together
Honoring the Past, Building on the Present, Innovating for the Future
Letter from Our President and CEO
DEAR FRIENDS,
As a result of your tremendous involvement and support of the Pulmonary Fibrosis Foundation (PFF), we have achieved important milestones that are making a real difference for our patient community today and will continue to do so for years to come.
I also want to thank you for welcoming me into the role of President and CEO at the beginning of this year. It has been my honor to serve this organization since 2011. Over time, my responsibilities have grown alongside the Foundation, and I am incredibly proud of the work our team does every day.
My commitment to this mission is deeply personal. In 2014, my mother was diagnosed with idiopathic pulmonary fibrosis, a moment that came as a complete shock to our family. Like so many others, we were suddenly navigating an unfamiliar and challenging journey. That experience strengthened my sense of purpose, and my mother’s memory continues to fuel my devotion to this community.
We were extremely fortunate to appoint Dr. Amy Hajari Case as Chief Medical Officer and Dr. Wayne Pan as Chair of the Board. Dr. Case is a leading clinician and educator in interstitial lung disease (ILD) and has played a critical role in shaping the PFF’s strategic direction. She is a passionate advocate for patient education and has led the development of trusted, accessible resources to support individuals and families living with pulmonary fibrosis (PF).
Dr. Pan, Medical Director of San Francisco Health Plan, brings extensive experience in healthcare research, products, and services, further strengthening our leadership and accelerating momentum toward a cure.
This year also marked several important milestones for the Foundation. We celebrated the 15th anniversary of our signature fundraiser, Broadway Belts for PFF!, with a record-breaking $559,000 raised in support of the PF community. We also launched an important new resource for those newly diagnosed with pulmonary fibrosis and interstitial lung disease: “PF Basics: Info for Newly Diagnosed Patients,” an online program designed to provide clear, compassionate guidance at the start of a patient’s journey. In addition, we successfully completed a pilot program with seven Clinical Associate sites within our Care Center Network and published the first study utilizing data from the PFF Community Registry.
As we launched the Pulmonary Fibrosis Foundation’s 25th anniversary year, we experienced a groundswell of support from across our community. That energy and commitment are building on our momentum and fueling progress across patient care, research, advocacy, and support. Thank you for being part of this progress and for your continued commitment to our shared mission.
Sincerely,
Scott Staszak President and CEO
Explore the modules
Supporting Patients with Trusted Education and Clear Information
In response to feedback from patients and caregivers, the Pulmonary Fibrosis Foundation launched
PF Basics: Info for Newly Diagnosed Patients, a new educational program designed to support individuals at the very beginning of their pulmonary fibrosis or interstitial lung disease journey. This curated, online resource addresses the most pressing questions patients face following diagnosis, offering clear, reliable information in an accessible format.
PF Basics features six self-paced modules covering essential topics, including understanding PF and ILD treatment options, navigating medical care, and available support resources. Developed by the PFF Medical Team and Programs Team with directinput from the patient community, the program ensures patients and families receive trusted guidance while reinforcing a critical message: they are not alone.
Be sure to stay up to date with new PFF programs and educational materials by signing up for the PFF monthly newsletter here.
The PFF also expanded its educational video offerings to confront common misconceptions and fill critical knowledge gaps. One video, Pulmonary Fibrosis Life Expectancy, features Dr. Sonye Danoff from the PFF Medical Team addressing the outdated statistic that suggests pulmonary fibrosis patients have a life expectancy of three to five years. She explains why this figure does not reflect the experience of all patients and how advances in care, research, and individualized treatment are changing outcomes. In a second video created this year, Liquid Oxygen in Under 3 Minutes, Dr. Danoff highlights the benefits of liquid oxygen therapy, encouraging patients and providers to learn more about this option as part of personalized care planning.
In addition, ILD Day 2024 brought together nine patient advocacy organizations to raise awareness and understanding of interstitial lung disease and pulmonary fibrosis. The day featured an educational webinar, The Journey to Diagnosis: Process, Evaluation, and Your Care Team, which explored how ILD is recognized, how diagnoses are made, and the roles of the care team. The presentation also emphasized patient self-advocacy, equipping individuals with the knowledge and confidence to take an active role in their care.
Community and Events Drive Record Impact for the PFF
The Pulmonary Fibrosis Foundation achieved record-setting fundraising and engagement through its national events and community-driven initiatives, reflecting the strength and commitment of the PF and ILD community.
The PFF Walk program raised a record $1.2 million through walks held in Pittsburgh, the NYC Metro area, the Bay Area, Chicago, Dallas, Washington, D.C., and on National Walk Day. More than 2,800 participants took part nationwide, raising both funds and awareness for people living with pulmonary fibrosis and interstitial lung disease.
The PFF’s single largest fundraiser, Broadway Belts for PFF!, celebrated its 15th anniversary with a record-breaking $559,000 raised. The event brought together Broadway’s brightest stars for an unforgettable evening hosted by Tony Award–winning actress and comedienne Julie Halston. During the celebration, the 2025 Ralph Howard Legacy Award was presented to PFF Advocate, Todd Tullis, who honors the memory of his mother, Kathy, through his generous support of the PFF. As a lifelong Broadway fan, Todd has embraced Broadway Belts and every fundraising opportunity with the Foundation to serve others affected by PF.
Patient advocates continued to play a vital role in raising awareness and inspiring support. PFF Ambassador Bill Ashley completed a remarkable 109-mile walk through the Florida Keys as part of his Keys to a Cure Walk, raising funds and awareness while building connections along the way. His journey was featured in the Foundation’s Father’s Day appeal. Dionn Tunis, also a PFF Ambassador, shared her story during Pulmonary Fibrosis Awareness Month (PFAM), reflecting on the shock of diagnosis and the importance of accepting support while adjusting to life with ILD. Through her advocacy, Dionn reminds patients that they are not alone and that the PFF can help connect them to the people and resources they need throughout their journey. She further advances the PFF’s mission by supporting Team PFF through her annual bowling fundraiser, Strike Out ILD.
These efforts underscore the power of community, storytelling, and shared purpose in advancing the Pulmonary Fibrosis Foundation’s mission to improve the lives of patients and families nationwide.
November 7-8, 2024 Virtually Online
PFF Education Symposium: A Virtual Success for the PF Community
In November 2024, the PFF Education Symposium brought together hundreds of patients, caregivers, family members, and loved ones for two days of virtual learning. This online conference offered the latest insights in research, disease management, caregiving, and the power of storytelling, all from the comfort of home.
Over 400 participants from across the country joined the event, engaging with the PFF’s expert Medical Team and guest speakers on a wide range of topics. From symptom management and clinical research updates to routine testing and caregiver support, the program delivered high-value content tailored to the real-world needs of people living with PF and those who support them.
Highlights included the Clinical Trial Innovation Series , which showcased current studies and emerging therapies, and an engaging “Pulmonary Fibrosis 101: Fact vs. Fiction” discussion that clarified common misconceptions about PF. Participants connected with their fellow community members during the Mix ’N Mingle Networking Session where stories were shared, support was provided, and comfort was found with others facing similar experiences.
The Symposium’s success reinforces the PFF’s commitment to education and support. By expanding access through a virtual platform, the Foundation ensured that essential resources and expert insights reached a broad audience — strengthening knowledge, confidence, and connections within the PF community.
Looking ahead, the next virtual PFF Education Symposium is already slated for November 12-13, 2026, promising another opportunity to learn, connect, and grow together.
Legislative and Policy Advances in Pulmonary Fibrosis Care and Research
The Pulmonary Fibrosis Foundation (PFF) continued its efforts to improve access to supplemental oxygen by advancing bipartisan legislation known as the Supplemental Oxygen Access Reform (SOAR) Act.
Working alongside a broad coalition of lung and respiratory health organizations, the PFF helped support the development and introduction of the legislation in both the 118th and 119th Congresses, reflecting sustained, bipartisan interest in addressing long-standing challenges in oxygen access.
The SOAR Act is built on four core pillars designed to make supplemental oxygen more patient-centered and clinically effective. The first pillar focuses on improving portability and flexibility so patients can remain active and engaged in daily life.
The second addresses access to liquid oxygen by removing it from the competitive bidding process and adjusting reimbursement for durable medical equipment (DME) providers. The third pillar emphasizes education and adherence by ensuring access to respiratory therapists through DME providers, helping patients, families, and caregivers properly understand and use prescribed oxygen therapy. The final pillar seeks to standardize oxygen orders, reducing confusion, fraud, and delays in care.
To build momentum for the SOAR Act, the PFF engaged its patient and healthcare provider community to raise awareness and demonstrate broad support for reform. These efforts included coordinated letters to the editor in multiple publications, making supplemental oxygen access a priority issue during the Foundation’s annual Hill Day, and ongoing advocacy throughout the year.
In addition to advancing the SOAR Act, the PFF pursued other key advocacy priorities aimed at strengthening pulmonary fibrosis (PF) research. These efforts included ensuring PF eligibility for research funding within the Peer Reviewed Medical Research Program in the Department of Defense, as well as securing the inclusion of pulmonary fibrosis report language in the National Heart, Lung, and Blood Institute section of the Labor, Health and Human Services appropriations report. Together, these initiatives underscore the PFF’s commitment to improving both access to care and sustained federal investment in pulmonary fibrosis research.
Stay up to date on the latest PFF advocacy initiatives by signing up as a PFF Advocate! You will receive advocacy alerts to contact your members of Congress to ask for their support when there is an important advocacy issue that impacts the PF community.
Bringing Expert Care
Closer to Home
The Pulmonary Fibrosis Foundation Care Center Network (CCN) recently completed a successful pilot program designed to expand access to high-quality care for people living with pulmonary fibrosis and interstitial lung disease in rural and underserved communities.
This new program paired seven new Clinical Associate sites with established Care Center Network sites in larger communities, creating partnerships that extend expert care, clinical guidance, and PFF resources to areas where specialty care is often limited. The initiative aims to connect more patients with providers who are committed to advancing the diagnosis and management of PF and ILD.
Building on this work, the Care Center Network’s Rural Health Outreach Committee is continuing to study how best to deliver care to patients in rural and less populated areas. The committee is examining models that improve coordination between specialty centers and community providers, reduce barriers to access, and ensure that patients receive timely, expert-informed care regardless of where they live.
The PFF is also actively collaborating with the Veterans Administration medical system to better serve veterans living with PF and ILD. Evidence suggests that the prevalence of pulmonary fibrosis may be higher in the VA population due to factors such as age, sex, and higher rates of tobacco exposure compared with the general population.
Many PFF Care Center Network sites have affiliated VA hospitals, creating a strong foundation for collaboration.
Through a hub-and-spoke model, Care Center Network sites serve as clinical hubs while affiliated VA hospitals function as spokes. This approach allows teams to share expertise, align care practices, and coordinate resources to deliver optimal, patient-centered care for veterans.
Together, these efforts reflect the PFF’s ongoing commitment to expanding access to expert care and ensuring that all patients, including those in rural communities and the veteran population, receive the highest standard of PF and ILD care.
Advancing the Science of Pulmonary Fibrosis: Two Key 2025 Research Breakthroughs
The American Thoracic Society International Conference was held in San Francisco in May. Two highly anticipated sessions gave additional insights into the topline positive results from Boehringer Ingelheim’s two phase 3 FIBRONEER-IPF and FIBRONEER-ILD studies. The 52-week data was published in the New England Journal of Medicine, Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis and Nerandomilast in Patients with Progressive Pulmonary Fibrosis, for your reference.
In both studies, nerandomilast was compared with placebo in some volunteers who were on antifibrotic therapy already (pirfenidone or nintedanib) and some who were not. In both studies, nerandomilast was shown to slow decline in lung function as measured by forced vital capacity (FVC), thereby meeting its primary endpoint. This was consistent whether nerandomilast was taken alone or with another antifibrotic agent.
This data has been submitted to the FDA in hopes that it will be approved for use in patients living with both idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF).
At the time of this publishing, Nerandomilast has been approved by the FDA for both IPF and progressive pulmonary fibrosis (PPF).
Patient experiences: A new study highlights the challenges of IPF
The scientific community deepened its understanding of the patient experience through a new research paper. A multidisciplinary research team published a study titled “Perspectives of people living with idiopathic pulmonary fibrosis: a qualitative and quantitative study” in BMC Pulmonary Medicine. This work explored lived experiences through interviews and broader survey data, revealing the significant daily challenges faced by individuals with IPF. Jessica Shore, Senior Vice President of Clinical Affairs and Quality at the Pulmonary Fibrosis Foundation, contributed to this research, helping bridge the patientcentered perspective with clinical relevance.
Participants:
• 52% of survey participants were male, and 48% were female
• 54% used supplemental oxygen
• 34% had never been exposed to an antifibrotic
Top sources of information about their IPF diagnosis:
• Their healthcare provider
• The internet
• Support groups
Symptoms: Most participants had one or more of shortness of breath, fatigue, or cough, and over 40% described these symptoms as very burdensome.
Antifibrotic use: The most common reason for not starting an antifibrotic was, “I am waiting to start treatment until my symptoms worsen.” For those treated with antifibrotics, 78% agreed with a statement that their antifibrotic gives them hope even though around 90% had at least one side effect. Together, these studies — one expanding therapeutic options and another amplifying the voice of people living with PF — reflect a balanced and meaningful progression in PF research: striving for better outcomes today while listening deeply to those most affected.
Class of PFF Scholars
The Pulmonary Fibrosis Foundation (PFF) is helping to shape the future of PF research through its PFF Scholars program. This year, six promising early-career scientists have each been awarded $100,000 to study pulmonary fibrosis.
These grants are designed to jumpstart their research careers, giving them the support they need to compete for even larger grants in the future and to stay focused on PF for the long term. By investing in these rising stars, the PFF is building a pipeline of dedicated researchers who will keep exploring new ways to understand, treat, and ultimately cure pulmonary fibrosis for years to come.
KRISTIN BERGER, MD
Weill Cornell Medical College
Proposal Title: Associations of CTAssessed Airway Diameter and Clinical Outcomes in Pulmonary Fibrosis
This proposal is funded by Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. Kristin Berger is an Instructor in the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medical College. She completed her undergraduate studies in Biology through the Honors Program at Susquehanna University, where she also pole vaulted as a member of the track and field team. She then received her MD at the Penn State College of Medicine. She underwent internal medicine residency training at the University of Pittsburgh Medical Center followed by fellowship training at New York-Presbyterian/Weill Cornell, where she also received her master’s degree in clinical and translational investigation supported by the NHLBI T32. She has clinical interests in outpatient management of interstitial lung disease patients and critical care medicine. Dr. Berger’s research interest involves early identification and prognostication of interstitial lung disease, and she is currently investigating radiographic biomarkers of disease.
SARAH L. KHAN, MD, MHS
Johns Hopkins University School of Medicine
Proposal Title: Pulmonary Hypertension
Prediction in Patients with Interstitial Lung Disease
This proposal is funded by the Hastings Foundation
Dr. Sarah Khan is a Pulmonary and Critical Care fellow at the Johns Hopkins University School of Medicine. She completed her medical degree at Drexel University in Philadelphia followed by internal medicine residency and chief residency at Boston University Medical Center. During her fellowship, she has conducted research on radiographic phenotypes of interstitial lung disease-associated pulmonary hypertension and obtained a master’s in health science and clinical investigation from the Bloomberg School of Public Health. For her current proposal, Dr. Khan will use changes in radiographic and physiologic parameters over time to predict which patients with interstitial lung disease are at the highest risk of developing pulmonary hypertension. Her overarching goal is to generate evidence to inform standards of care for diagnosing and managing pulmonary hypertension related to interstitial lung disease and ultimately improve outcomes for affected patients.
One-quarter to half of all patients with interstitial lung disease (ILD) have comorbid pulmonary hypertension (PH). Patients with ILD and PH (PH-ILD) have worse symptoms, more functional limitations, and poorer survival compared to those without PH.
Despite the high prevalence and serious implications of PH, there are currently no guidelines to recommend when, how often, and with which tests ILD patients should be screened. Current screening practices for PH-ILD vary widely among ILD providers, so there is a dire need for clinical guidelines. We propose that we may be able to combine two clinical measures which were found to be predictors of PH in patients with scleroderma to identify which ILD patients at risk for PH and should, therefore, be targeted for screening. The first of these potential predictors is based on changes in pulmonary function testing (PFT). The second potential predictor is the extent of lung involvement seen on chest computed tomography (CT). We hypothesize that ILD patients’ risk for PH can be predicted based on their chest CTs and changes in their PFTs over time.
XUE LIU, PHD
Cedars Sinai
Proposal Title: Regulation of HER2 Activation in Fibroblast Invasion and Pulmonary Fibrosis
This proposal is funded by the Hastings Foundation
Dr. Liu’s research focuses on the cellular and molecular changes involved in the pathogenesis of Idiopathic Pulmonary Fibrosis (IPF). Utilizing cutting-edge approaches such as single cell multiomics analyses and rodent animal models, his work aims to investigate the mechanisms driving the invasive fibroblast phenotype in pulmonary fibrosis and to explore the dysregulated genetic programs and niches of alveolar progenitor cells in aging and IPF.
SCOTT M. MATSON, MD
University of Kansas
Proposal Title: Metabolomics of preclinical pulmonary fibrosis
This proposal is funded by the Johanneson Family
Scott M. Matson, MD is an Assistant Professor of Medicine in the division of Pulmonary, Critical Care and Sleep at the University of Kansas. He sees patients in the Interstitial Lung Disease and Rare Lung Disease clinic at KU and attends in the medical intensive care unit while serving as Associate Program Director for the fellowship where he directs the fellowship research program. He is a clinician-scientist focused on translational research in interstitial lung diseases using multi-omics techniques to identify risk factors and biomarkers for ILD development, progression, and treatment prediction.
ABRAHAM (SCOTT) MCCALL, MD,
PHD
Vanderbilt University Medical Center
Proposal Title: HIF2 modulation of alveolar repair in pulmonary fibrosis
This proposal is funded by Boehringer Ingelheim Pharmaceuticals, Inc.
Dr. A. Scott McCall is an Instructor in the Division of Allergy, Pulmonary and Critical Care Medicine at Vanderbilt University Medical Center. He completed his undergraduate work at Kansas State University then attended Vanderbilt University School of Medicine for his MD and PhD in Pharmacology. He was clinically trained in Internal Medicine then a Pulmonary and Critical Care Fellowship at Vanderbilt University Medical Center where he has joined faculty as a physician-scientist. Much of his research has been driven by IPF transcriptional data and patient-derived organoids to understand the injury repair process and stem-cell function in the lung. By modifying the underlying injury-repair processes, his goal is to bring patient-tailored therapies to the bedside by developing new and innovative therapeutic solutions and repurposing existing compounds to treat fibrotic lung disease.
JEFFREY STUREK, MD, PHD
University of Virginia
Proposal Title: The Role of B-1 Cells and IgM in Pulmonary Fibrosis Pathogenesis
Funded by the Buckeye Foundation, the Chuck and Monica McQuaid Family Foundation, and the Jenny H. Krauss and Otto F. Krauss Charitable Foundation Trust, in memory of Stephen N. Dirks
I am a physician-scientist with a research program focused on translational pulmonary immunology. I grew up in Columbia, Missouri and attended undergraduate school at Augustana College in Rock Island, Illinois. I pursued my M.D. and Ph.D. degrees through the Medical Scientist Training Program at the University of Virginia (UVA). I followed this with residency and chief residency in Internal Medicine, and fellowship in Pulmonary and Critical Care Medicine, all at UVA. During the research phase of my fellowship, I gained experience in B cell immunology and translational research methods. In 2019 I came on faculty and was selected as an invited scholar in the Integrated Translational Health Research Institute of Virginia (iTHRIV) Scholars Program, a two-year career development program focused on early career translational health researchers. My clinical focus is on immunemediated and scarring lung diseases, including interstitial lung disease. My research spans the range of the translational spectrum from clinical to basic laboratory work to understand lung injury and repair. As a dualtrained physician scientist, I feel it is my calling to work at this interface. Outside of the hospital I enjoy staying physically active and spending time with my wife and three children.
Pulmonary Fibrosis Awareness Month 2024:
Every Breath, Every Story
In September 2024, the PFF united the community for Pulmonary Fibrosis Awareness Month (PFAM), under the heartfelt theme “Every Breath, Every Story.” This annual campaign put a spotlight on the strength and resilience of people affected by PF and ILD while driving national awareness about these challenging conditions.
The month’s signature #BlueUp4PF initiative saw buildings and landmarks in all 50 states shining blue across communities, symbolizing solidarity and inviting broader public recognition of PF. By centering voices and sharing trusted information, PFAM 2024 elevated visibility for PF and ILD like never before — fostering connections, empowering advocates, and moving the mission forward with Every Breath and Every Story.
In celebration of the PFF’s 10 year anniversary, the Foundation also released a compelling short video to re-introduce ourselves to the PF community.
Throughout the month, the PFF amplified education and community connection with a robust lineup of activities that energized supporters both online and in person. The Foundation’s “30 Facts in 30 Days” social media series delivered daily facts about PF and ILD, inviting followers to like, share, and comment to broaden the campaign’s reach.
A cornerstone of the month was the “Portraits of PF” series, which shared powerful personal stories. From individuals living with PF and caregivers to those who lost loved ones, and transplant recipients, this powerful series reminded audiences all around the world that behind every diagnosis is a human story.
Meanwhile, National Walk Day served as a unifying moment for supporters nationwide as patients, families, and friends walked together for education, support, and hope.
The PFF Community Registry Drives Discovery
The PFF Community Registry reached exciting new milestones that are accelerating research and expanding our understanding of PF and ILD. Launched in July 2022, this innovative research study invites people living with PF or ILD, lung transplant recipients, caregivers, and family members to contribute their experiences through online surveys. These surveys create a rich, communitydriven dataset that researchers can use to ask new questions about disease impact and outcomes.
A major 2024 highlight was enrollment growth: the Registry surpassed 2,200 participants, drawing individuals from across the United States. This expanding cohort provides a valuable foundation for real-world research, empowering scientists with insights that go beyond traditional clinical records. Every survey completed represents a voice in the fight for better care and, ultimately, a cure.
Building on this momentum, researchers published the first peerreviewed study using Community Registry data in Annals of the American Thoracic Society. The study, Interstitial Lung Disease Patients’ Global Impressions of Symptoms, Severity Ratings, and Meaningfulness of Changes Over Time sought to explore a better understanding of how patients living with ILD rate and categorize symptoms, how differing levels of symptom severity affect lived experiences, and how patients derive and apply meaningfulness to change in symptoms.
The combination of growing participation in the Registry and the emerging research publications underscore the Registry’s role as a powerful engine for discovery. By engaging the PF community directly in research, the PFF Community Registry is not only broadening the scope of scientific discovery, but also ensuring that the lived experiences of patients, families, and caregivers help shape the future of PF care and research.
Meet the PFF Board of Directors
The Pulmonary Fibrosis Foundation is proud to have a committed Board of Directors to help guide the activities that support our important mission. Members of the Board are actively involved in the PFF’s activities and participate in fundraising, promoting awareness, and advocating for the pulmonary fibrosis community.
The PFF’s Directors lay the groundwork for the Foundation’s strategic vision and contribute significantly to resource development. A central focus of the Board of the Directors is fundraising.
Wayne T. Pan, MD, PhD, MBA CHAIR
Patricia (Pat) Rosa, M. Ed. VICE-CHAIR
Martin Attwell SECRETARY
Laurie Chandler, CFP TREASURER
Grant Ballantyne, CPA
Harold R. Collard, MD
Terence F. Hales
Julie Halston
Jeff Harris
Susan S. Jacobs, RN, MS
Heather Kagel Pankaj “PJ” Kamani
Devi Kumar-Nambiar, JD, MBA
MEMBERS EMERITI
Retiring members of the PFF Board of Directors who have made exceptional contributions to the Foundation are honored with the status “Member Emeritus.”
Daniel M. Rose, MD
Chairman Emeritus
Colleen Attwell
Joseph Borus, Esq.
Thomas E. Hales
Mike Henderson
Chairman Emeritus
Dave Steffy
Stephen A. Wald, PhD
STATEMENT OF FINANCIAL POSITION
AS OF JUNE 30, 2025
STATEMENT OF ACTIVITIES
YEAR ENDED JUNE 30, 2025
The full audited financial statements are available online at pulmonaryfibrosis.org or can be requested by calling
ALLOCATION OF EXPENSES
PFF 2025 Donors
$250,000 AND GREATER
Boehringer Ingelheim
Bristol-Myers Squibb
The Estate of Denise Kay Harris
$100,000–$249,999
Avalyn Pharma
Nelda Hagaman
The Hastings Foundation
Chuck & Monica McQuaid
The Estate of Nelly Pease
United Therapeutics Corporation
The Estate of Ronald Zawacki
$50,000–$99,999
Patricia Bonezzi
Doug and Gay Lane
Charitable Foundation
Endeavor Biomedicines
Genentech
The Hales Family Foundation, Inc.
K. Wendell and MaryAnn Reugh
Family Fund
The Estate of Richard A. Lieboff
Liquidia Corporation
Merck & Co., Inc.
Pliant Therapeutics
Steffy Family Foundation Fund
Vicore Pharma AB
$10,000-$49,999
AbbVie
Accredo
Liz Armstrong
Mary Ann C. Aug
Christian Genevieve Bennett & Family
Paul & Susan Bergna
Broadway Cares/ Equity Fights Aids
The Bruce R. and Madelyn G.
Snyder Foundation
Patricia Campbell
George Carroll
Jeffrey & Pamela Choney
Edward J. Clark
Mark Cochran
Terrance & Charlene Connolly
COPD Foundation, Inc.
CSL Behring
CVSHealth
The Daryl Steven Roth Foundation
The Decamp Family Foundation
Bill & Connie Doty
The Dunn Family
Charitable Foundation
Barbara Fronczak
Leo & Susan Giguere
GlaxoSmithKline
The Hamilton Family
Charitable Fund
Hand Foundation, Inc.
INOVA Health System
Insilico Medicine US, Inc.
Jenny H. Krauss and Otto F. Krauss
Charitable Foundation Trust
Johnson & Johnson
Pankaj & Sonal Kamani
Larry Kanter
Karen A & Kevin W Kennedy Foundation
Jonathan Karoly
Vern Kertis
Larry L. Luing Family Foundation
Liberty Mutual
Teresa Lim
Mannkind
McWethy Family Foundation
Mediar Therapeutics, Inc.
John Mezzo
The Estate of Michael Mignano
Christopher Mileo
Sallie Naillieux
Nissanoff Family Fund
Northwestern Medicine
Nycticorax Nycticorax Fund
Tony Origlio
Orsini Specialty Pharmacy
Pulmovant, Inc.
PureTech Health
The Estate of Lynne
Rauscher-Davoust
Linda Rosecan
S and A Purington Family Trust
Virginia T. Severinghaus
William Smead
Doris Jean Southerland
Shomala Tambyraja
Scott Thompson
Trevi Therapeutics
Tvardi Therapeutics
PFF 2025 Donors
Ross & Grier Twiddy
Kate Wallace
The Estate of Nancy Lee Webb
Sean & Allie Webster
William B. O’Connor Fund
The Winfield Foundation
Kathleen Wittau
$5,000–$9,999
Alphanet, Inc.
Apple, Inc.
Martin & Colleen Attwell
ATyr Pharma, Inc.
Nelson & Sylvia Ball
William & Christine Barry
Baylor Scott and White Health
Raymond Beebe & Mary Boland
Philip Bolas
The Bonner Family
Private Foundation
Bruce & Patty Cameron
Amy Case, MD
Clarke & Laurie Chandler
The Charlotte and Jamil Azzam
Foundation Kanaly Trust
Columbia University-NYP
Interstitial Lung Disease Program
Creative Planning
Diane Destefanis
Ashley Donoso
Ed Lucas Foundation, Inc.
Thomas Elden
Garden State PF Support Group
Eric Gibson
Julie Halston
Dean & Susan Harrel
Randy Harris
Carolyn Hicks
Suzanne Hill
Heidi Hoblit Graham
Holson Family Foundation
Honkus-Zollinger
Charitable Foundation
Robert & Judith Hughen
Doug & Susan Jacobs
Rama & Sonia Jager
Jason Fellman Music, LLC
James Johnson
Willie Kemp
The Kobrand Foundation
Linus Koopmeiners
Peter Kudler, M.D. & Nitsana Spigland, M.D.
Devi Kumar-Nambiar
Susan Lotty
Machhar Charitable Foundation, Inc.
David C. Mahoney
Tanya Mahoney
Marcia and Ned Kaplin Foundation
Martin Family Foundation
Janice Massaua
Eric McCarty & Eric Perry
Cori McKenzie
David McNinch
Microsoft Matching Gifts Program
Adam & Jennifer Mills
The Nederlander Organization
Matt Nemeth
New York Presbyterian Hospital
Novartis Pharmaceuticals
Corporation
Deirdre OBrien
Oil Solutions Group, Inc.
Linda Olson
One Breath at a Time, Inc.
Wayne Pan
Hansa K. Parekh
Hiren & Patti Patel
Charlotte Plotnick
George & Nancy Poulsen
Rosa Family Charitable Foundation
Gordon Sako
Edward Schulte
Romalda Schwed
Theresa Simko
Jan Simmons
The Estate of Ronald L. and Martha A. Spraetz
Staley Family Foundation
Scott Staszak & Laure Dussubieux
Stoelting Co.
Claire Tardy
The Thomas Family Fund
UC San Francisco
UPMC
Vermeer of Michigan
Chris Warren
Sharon Weston
Ann Zeiler
PFF 2025 Donors
$2,500–$4,999
Abbott Laboratories
Robert & Marjory Abrams
Ben & Jan Anderson
Julie Andrews & Family
Brian Bailey
Tim Bishop
Alan & Robin Bochner
Dan & Zoë Bubany
Mark Burke
Gregory Byrd
John & Mary Agnes Carroll
Jane Casey
Kristi Cavaliere
Jo Carol Clark
Corebridge Financial
Bernard Coulie, MD, PhD
Laura Cox
John Curnutte
Neva Curoe
Cory Dellinger
Draper & Kramer, Inc.
Darrel Everman
Fletcher Foundation, Inc.
GAF Materials
Loraine Gardner
Lucinda Gonzalez
Paul Guyre
Lisa Hall
John & Ruth Hamstra
Harold D. Wright and
Hazel C. Wright Foundation
Andrew Harris
Jeff & Jennifer Harris
Michael Hierl
Joan M. Hinckley
Kimberly Hossa
Mary Hynes
Jeffrey Jancula
Daniel Jorndt
Ronald Justus
Kalaris Members
Ralph Kennedy
John Kirkpatrick, MD
Sam & Susan Kirton
Diane Laboda
Martha Lamb
Robert Wendell Logan
Mildred Magallanes
The Magic Bag Bad Kitty, LLC
Anonymous
Patti Meyers
Gregory Muir
Megan Nicely
Bruce & Beverly Olson
The Naren & Ila Patel Family
Paul Patterson
The Lesley Pattison Family
Paul Erb and Barbara Belt
Gifting Fund
Pamela Peterson
Jan Pickett
Mark Plourde
Susan Potenza
Harvey Resnick, MD
Sharon Rhoads
The Estate of June H. Ritchey
Charles Russman
Schmidt Kaeser Family Fund
Alan & Pam Schwed
Ellen Sides
John & Patricia Smeaton, MDs
Smith, Gambrell & Russell, LLP
Delores Stricht
Student Respiratory Care
Association
Alyson Teague
Barbara Thompson
Tom & Ellie Slovis Family
Philanthropic Fund
Todd Tullis
United Charitable -
Evans FUNdation
Randy Wacker
William and Caroline Tellez
Family Charitable
Jonathan Winslow
$1,000–$2,499
12 Oaks Senior Living
A+E Networks
AbbVie Foundation Employee
Engagement Fund
Alton Absher
Patrick & Katy Ahern
Kristen Alden
Stephanie Jae Alderman
Donald Allison
American Express Charitable Fund
American Legion Riders
Chapter 283
PFF 2025 Donors
Amesbury Industrial Supply Co.
Kyle Anderson
Walter & Eleanor Angoff
Iqbal Anwar
Selim & Elizabeth Arcasoy
Chris & Autumn Armstrong
Col. Robert Armstrong, USAF, RET
Autumn Lake Friends
Ali Bajwa
Frances Bangert
Tim & Margaret Barrett
Patricia Bartels
Donna Barten
TC Bartoszek
Jeffrey Bassett
The Bay State Federal Savings
Charitable Foundation
Anne Friday Beck
Bernard Belkin
Bell-Reeser Charitable Fund
Suma Bellur
Jody Benson
Michael & Debbie Berger
Lynn Bienas
Andrea Billhardt
John Bishop
Brad Blackwell
Boeing Company Gift Match
Robert Bohan
Thomas & Jean Boltz
Jeanne Boretti
Claira Jean Boyd
Howard Boyd Tolley
Susanne Brabrand
Marla S. Brady
Virginia Brady
Nicholas Braun
Judy Breen
Chad & Alicia Brinley
Margery Brittain
Rebecca Brittian
Family & Friends of
Michael Brophy
Benjamin Brown
Dick & Monica Brown
Karen Brown
Stephanie Bruce
Ashley Bucci
Christian Buchanan
Roy & Katherine Bukstein
Billy Burgess
John Burgess
Adrienne Burroughs
Charlie & Heather Bustin
Butler Family Fund of the Community Foundation
Curt Cabot
Sharon Callahan
Barbara Calvo
Campbell Scientific, Inc.
Larry Cantrell
David & Ruth Castle
CEA Group, LLC
Charitable Adult Rides & Services, Inc. (CARS)
John Cheshire
Lily Cheung
Karen Christensen
Mary Clair
Dagan Clark
Ron & Ann Clark
Don & Kim Clausen
James Cmunt
Michael & Nicole Cochran
Randall Cochran
Rebecca Cohen, MD
Wendy Cohen
Janice Coker
Frank & Barbara Colucci
Constellation Energy Group Foundation
Jackie Cooney
Bernard Costello
Judy Craig
Jason Crawford
Gordon Crocker
Gayle Crowell
Timothy Culbreth
Brenda Cummings
Keith Cummings
Roger Cummins
Scott & Kathleen Cunningham
CVS Health Foundation
Robert Dalrymple
Robert Dalsemer
Anonymous
Deborah Davis
Eric Dedrick
Delamar West Hartford
Laura Demore
PFF 2025 Donors
Cheri DePoy
Claire C. Desai
Carlinda Dirks
Patrick Donnelly
Joseph Doose
Michael Dorf & Maury Collins
Chris Doughty
Sandra Duvic
Darryl Embrey
Robert & Jackie Estrella
Evans Construction Consulting
Expressworks International, LLC
Rev. Reid D. Farrell
Feldman/Motzkin Charitable Fund
John Ferretti
Carol Feula
Francine Fielding
Dianna Finch
First Rate
Kevin Flaherty
Fleet Feet
Donna Flewellyn
David & Amy Forsee
Dianne Foster
John Fromularo
Brad Fulkerson
The Gaffney Foundation
Victoria Gamerman
Christine Kim Garcia
Howard Gardner
Rachel Garner
Herbert Gedge
Anthony & Donna Gentile
Jerry Gerdes
Mish Gerhart
Anthony Giordano
Harley Clayton Goff
Karen Goldblatt
Tommy Goodwin
Google Matching Gift Program
Graco
Matthew Grady
Graham Family Giving Fund
Grainger Matching Charitable Gifts Program
Kevin Green
Gregory Flood and Linda Korbus
Giving Fund
Paul Groenwegen
Nancy Gut
John Gutgsell
Andrew Gutierrez
Hack Family Fund
Harry & Lynne Hallowell
Mary E. Halston
John Hamlin
Sandra Harasym
John Hargrove
Andy Hartman
Susan Hartong
Dawson & Audrey Heck
Susanne Heim
Mike & Donna Henderson
Judy Henderson Butler
Louis Henry
Richard Hermes
Hightower Financial Principles, LLC
Neil Hildick-Smith
Ron Hilliard & Helen Carlos
Jeff & Cindy Himmel
Ed & Julie Holland
William Holtz
Irene Horine
Deborah Howard
Herbert & Caryle Howe
Howland Family Foundation
Amy Huitt
Humana
Gregory Hummel
Illinois Tool Works Foundation
Intel Foundation
Interiors on the Move
Diane Ireland
Bill & Margaret Ismon
Eric & Katie Iverson
Dan & Dot Ivey
Nancy Jackson
Cathy Jacobs
Jim Jakobek
Edward Jamieson
Christian Jewett & Breada Farrell
Sheila Juthani
Dhruti Kalathia
Anjali Kamani
Naynesh Kamani
Sanjay Kamani
Robert Kaner
Laurence P. Karper, MD
Dave Katt
PFF 2025 Donors
Ethan Kaufman & Nicole Efros
Virginia Keeshan
Glenn & Christine Kelly
Elena Khan
Luanne Kip
Seth Klein
James & Lynne Kloek
Kenji Kojima
Greg & Michele Kozar
Christine Kulina
Gail E. Labbe
Joseph A. Lasky, MD
Chuck & Jennifer Lawless
Kristin Lazatin
Scott Leatherbery
Sue Leatherbery
David J. Lederer, MD, MS
Carolyn Lee
Joyce Lee, MD
Eric Lefebvre
Rebecca Lemon
Deb Lewis
Rebecca Lilly
William Line
Shirley Liu
Chad Livingston
Kerry Lomando
Nicolette Lomando
Sean Lonergan
Warren & Denise Loveland
Sharon Luikaart
Sonia Luna
John Lundin
Larry & Shannon Lynn
Joyce MacDonald
Tim Machajewski
Richard Magnus
Robert & Jean Markley
Margery Martin
Michael Mason
Ingeborg McCarty
Brenda McGehee
Agnes McGrail
Patricia McKee
Rhodes Vernon “RV” Meadors
Danny & Chaurley Meneses
Metro Services Group
David Miller
Michael Miller
Jeff Mills
Kevin Mitchell
Mitzner Family Gift Fund
Stephen Monas & Maggie Megaw
Morgan & Jones, PLLC
Robert & Marsha Morris
Movement Foundation, Inc.
Barbara J. Murphy
John Murray
Chris Nachtrab
Barbara Newton
Zayna & Roya Nisar
Winifred Nishimine
James Michael & Marian Norton
Karen Nuzzo
Lisa Oakman
Nels Olson
Carol Osterman
Susan Ostertag
Bert & Susan Oyama
P3 Products
Palm Springs Region of Porsche
Club of America
Tom Panoplos
Bill Parsons
Pasadena Yacht & Country Club
Pamela Payne
Jeffrey Peters
Al Pfeiffer
Pfizer Foundation Matching Gifts
Program
Shelley Phillips
Richard Pierro
Charles & Isabel Polsky
Scott Poole
Matt Prichard & Family
Progressive Insurance Foundation
Quest Diagnostics
Randall Family Charitable Fund
Divy Ravindranath, MD
Richard Raymond
Theresa L. Reed
Jennifer Reenan
Theresa Reid
Cindy Reierson
Brian Rieger
Elizabeth Ritchey
Eric & Sue Robbins
Diane Robinson
Robert Robinson
Rockwell Automation
PFF 2025 Donors
Rome Family Charitable Fund
Christian & April Rothe
Brian Ruder
Jewel Rufe
Sarah Rumph
Linda Runyon
Karen M. Ryan
Edwin Sakamoto
Rosemarie Sansone
The Mitesh & Amita Satasia Family
Carol Satler, MD, PhD
Anonymous
Michael Savino
Wilhelmina Savoca
Peter Schafer, PhD
Steve & Susan Schnoll Family
Olin Schocket
Catherine Schroeder
Greg Schulz
Bruce & Roni Schwartz
Craig & Christine Scott
Carolyn Scroggin
Jonathan & Deborah Secrest
Lynn Segal Kogen
Christian Selleron
Divya Shah
Hemang & Bindiya Shah
Surekha Shah
Brian Shanahan
Shell Oil Foundation
Matching Gifts
Matthew & Leann Sheridan
Sam & Becky Sherstad
Gregory Silva & Cynthia Camp
Dhirendra Singh
Ellie Slovis
Jeffrey & Kimberly Smiejek
Richard Sneyers
Lawrence Snyder
Erin Soggs
SOLE Podiatry NYC
Josh Sonett, MD & Nancy Sonett
Nick Spano
David D. Spaulding
Richard & Linda Spencer
The Spenser Group
Robert St. Germain
John L. Stauffer, MD
Karel Steiner
The Stephanie & Micha Family
Bill Stevens
Donna Stone
Selma Stuart
Sudha and Ramesh Parekh
Charitable Fund
John & Nancy Sullivan
Josephine Svec
Phyliss Swart
James Swistock
Synopsys, Inc. & The Synopsys Foundation
Donna Talbott
Josh & Michelle Talley
Sandra Tansman
Phillip Tasto
Ross Taylor
Teresa L. Long Family Fund
Jay Thornhill
Rebecca Thornton
Thrivent Choice
Peter Thwaite
Leslie Tolle, MD
Byron Tomlinson
Matt & Alexa Tonner
Cal & Michele Trevenen
Jackie Trube
Carly Tsurudome
Steve Tucker
Fred & Julie Tufts
Tyler Tullis
The Tully Family
Patti Tuomey, EdD
Diane Turner
U. S. Bank Foundation
United Health Group Employee
Giving Matching Gift Program
Uniters NA, LLC
Scott Upham
USAA
Jared Van Hoon
Robert & Debra Wacker
Barbara Walters
Raymond Warner
Nancy Waters
Irene Watson
Austin & Barbara Waugaman
Kenneth Weaver
Leonard Weiser-Varon
David Wells
Joan Wenglikowski
PFF 2025 Donors
Martha Wentworth
Tom West
Michael Whitcomb
Michael Whitcraft
David & Teresa White
Kevin Whitley
Charles Whittington
Donald Whittington
Robert “Rob” Wildermuth
Willacker Action Committee
The William E. Franklin Charitable Fund
James Williamson
Jake Wolenberg
The Wolf Family Fund
Chloe Womack
The Wonderful Company
Janea Woodruff
Mark Zacharias
Nipul & Nita Zalavadia
Koorosh Zartoshty
$500–$999
Rose Acuff
Randy Adams
Adobe
Hilda Aguirre
Allan and Meline Pickus Foundation
Allstate Giving Campaign
Amesbury Dental Associates
The Amgen Foundation
Carol Amon
Monica Anderson
Barbara Anderson
Raman Anurag
Aon
Mike & Holly Ashley
Monica Asnani
Aspire Xdock, LLC
AstraZeneca Pharmaceuticals LP
Greg & Deborah Back
William Baert
Mary Anne Baker
Baker Family Foundation
David Balabanian
Jennifer Ballard
Becky Bangs
Bank of America
Charitable Foundation
Lyn Baranowski
Anonymous
Richard Barber
John & Darla Barger
The Estate of Paul A. Barimas
Marcy Barkan
Cynthia Barkett
Noah Barnby
Susan Barron
Kenneth & Margaret Bartels
Steve Baumgart
Ted & Judy Baumhauer
Bay Area Chest Physicians, PA
Bridget Beck
Laura Bell
Lee Ann Bell
Bernard & Jeanne Bertsche
Louis Betz
Suzanne Bianchi
Bical Auto Mall
Bill and Sue Cutri Fund of
The Pittsburgh Foundation
Bob & Stephanie Black
Richard Black
Diane Bloom
Bloomberg LP
Rayna Bogue
Mike & Sherry Bond
Greg Bottorff
Botzolakis and Beyderman Fund
Joey Bovona
Kathleen Bowden
Debbie Brackenridge
Gene Brannen
Joseph Braviak
Martin Brennan
Jeffrey Brenneman
Barbara Brenner
Catherine Brienza
Broadcom
Thomas Brogan
Brookfield Public Securities Group
James Brown
Theodore Brown
Zachary Brown
Lynne Budnovitch
Elizabeth Buenning
PFF 2025 Donors
Jayme Burgess
Shelia Burgess
Rick & Sherri Burkhead
Dennis & Carol Burns
Janet Busson
Dwight Butler
Cadence Design Systems
Galina Calderon
Bernadette Calocino
Tammara “Tami”
Campbell-O’Donnell
Thomas Cantwell, III
Justin Carbis
Patricia Carbone
Mark Carlson
Matthew Carmolli
Jim & Karen Carns
Rodney Carr
James & Jane Carter
Andrew Caselli
Diane Castelli
Kelly Cecutti
Albert Cejka
Cathy Chakos
Bill Charkow
Phillip Chase
Jennie Chen
Ryan Cheng
Sunny Cheong
Kimberly Chismark
Stephen Choe
Young & Jennifer Chung
CIGNA Foundation
Alan Cirilli
Cisco Systems, Inc.
Amy Clark
Ray & Tammy Clarke
Tona Clayton-Sarniak
Cleveland Clinic, J54
Alice Click
Janice Clifford & Family
Richard Cohen, MD &
Libby Cohen
Brendan Coleman
Colin Coleman
Heather Collins
The Conley Family
Charitable Fund
Margaret Conroy
Jane Cooper
Philip Cooper, DMD & Kathleen Cooper
Mary Beth Cormier
Gregory P. Cosgrove, MD
Dorothy Coyle Raclaw
Alan Cravitz
Rafael Crespo
Emily Crouch
Steve Croxton
Aaron Cruse
Bonnie Crystall
Sylvia Cuiman
Tom & Andrea Cygan
Aristides Damascus
David and Molly Pyott Foundation
Karina Davidson
Elizabeth Davies
Franklin De La Cruz
Davy & Giana De Santis
Francis DeBons
David & Tiffany DeCarlis
Deckers Outdoor Corporation
Tony & Claudia Deeb
Jim & Kathy Deichen
Nancy Dellheim
Patrick DePoy
Vinay Desai
Sharon Detore
Cheryl DeVincentis
Kim DeVries
Will DeVries
T. Michael & Dianne DeWitt
Lauren Dews
Adair Dillaha
David & Margaret Dines
Steven Dinger
Christopher Dixon
Jeff Douglas
Douglas D. and Elizabeth M.
Thomas Fund
Charlie Dozier
DRC Holdings, LLC
Keith Dricken
Stephen DuBois
Lynne Duffey
Zana & Phyllis Easton
Joan Eccleston
Thomas Edel
Jeannine Edmundson
James Eiting
PFF 2025 Donors
Gail Eldridge
Endetail
Patricia Engelman
The Eric and Isabelle Mayer
Charitable Fund
John Ericson
Barbara Esau
Evans Capital Corp.
Evolution Strategy Partners
Kathy Faria
Susan Farshidi
Donald Faye
Michael & Louise Fazio
Dan & Cynthia Feig
Maura Fennell
Americo & Anna Ferri
Kathleen Fields
Troy & Kacia Fiesel
Kate Finger
Tish Fisackerly
Kim Fisher
Cindi Fisse
Florida Diamond Sports Group
Joseph Floyd
George Flynn
Barbara Foley
Edward Foley
John & Marie Foley
Gary & Janie Forman
Jennifer Fowler
Gene & Donna Frett
Marilyn Freund
Dave Friedman
Marlyss Gage
Len Ganote
Jame Gardiner
Liz Garo
Michael Garvey
Wondwossen Gebre
Norman Geils
Flip & Carol Gianos
Denise Ginsberg
Michael Giordano
Glenbard Auto Body
The Goergen Foundation, Inc.
Susan Goldslager
John Goral
Joseph M. Grady
Camilla Graham
Colleen Graham
Annie Green
Gary & Karen Gregg
Karen Gregg
Maggie Guadamuz
Grace Guandique
Emilia Guevara
Scott Gunnison
Mark Hake
Ron & Pam Hall
Pam Halligan
Scott M. Hamberger
Carol Hamblin
Tim & Janet Hargrove
Harmonia Holdings Group
Derek Harris
Franco & Dana Harris
Mark Harris
Shawn Hartman
Pam Harwood
HCA Healthcare
Hearst
Albert J. Hebert
Judy Heck
Karen Heintzelman
Ben Hek
Robert & Donna Held
George Helock
Anne Henderson
Judith Ann Henderson
Jason Hendrickson
E. Brad Henning
James Henry
Leanna Herget
Anonymous
Hewson and Van Hellemont P.C.
Higuchi Donor Advised Fund
Mark & Elizabeth Hindal
Monika Hinse
Jonathan Hochberg
Christopher Hockett
Dustin Hoekstra
Carol Hoffman
Molly Hoffman
Derry Holland
Habeeb Hooshmand
Scott & Debra Hopkins
Kathy Howanek
Greg Howren
Fernando Hoyos
HPZS
PFF 2025 Donors
Jon Hubbard & Linda Nielsen
Hans Hull
Sharon Hunter-Lindsey
Alex Hurst
ICF
Ideas Plus Marketing Group
IndiLABEL
Gilbert Infinger
Intuitive Foundation
Nancy Iovino
Blake & Laura Jackson
Jeff & Margaret Jacobs
Karl Jaeger
Jan Wilhelm Charitable Fund
Lauren Janosy
Natalie Javadi
Chris Jenson
Ryan Jerwers
Linda Johnson
Mark Johnson
Greg & Jeanette Jones
Kristena Jones
Richard Jones
JP Morgan Chase Foundation
The Jurkovich Fund
Laura Justo
Heather Kagel
Vinaykumar & Varsha Kakadiya & Family
Emil Kakkis
Vipul & Kanan Kalathia
Mari Kaluza
Riki Kane Larimer
Jonathan Kaplan
Rohit Kapoor
Kapustiak Family
Joseph Kaufman & Janet Korin
Jad Kebbe, MD
Richard Keefer Jr.
Henry Keeshan
TJ Kelsall
Derek Kevra
Karl & Cathy Kevra
James Kie-Chul Ohn
Chris King
Mary Margaret King
Nancy Kitzmiller
Thomas Kitzmiller
Debbie Klein
Darlene Klinski
Paul Knorr
Carol Knutson
Kimberly Koh
Steven Koval
Alan & Martha Kruckemyer
Kevin Krueger
Robert & Karen Kupfer
L. Carl Dupree & Associates, Inc.
L3Harris Technologies
Eric Lanzendorf
Jason Lasky
Erin Lavelle
Kevin & Jean Lawlor
Joe Lear
Mary Ann Lee
Tammy Lee
Juliet Leftwich
William Lenhart
Lori Lesser
Beth Levine
Edgar Lewandowski
Dana Lindon
Joshua Lisle
Chris & Dawn Lissner
Roberta Little
Rick & Danelle Liwski
Eric & Sara Loken
Mike Longo & Laura Corcoran
Rick & Geri Lopatin
Diana Love
Elizabeth Lyda
Barbara Lynn
Thomas MacCrory
MADN Agency
Colin Magowan
Kunal Makwana
Christine Maloney
Catherine Manning
Ali Mansour
John Marco
Carl Marotzke
Nancy Marsh
Frank & Regina Martens
Emile Martin
Brett & Lindsay Masterson
Jordan Maxey
Patrick McCann
Robert McCauley
Kari McClain
John McClellan
PFF 2025 Donors
Thomas McGowan
Molly McMahon
Aaron McNeal
M. Lynn Meadows
Jake Meding & Annice Coughlan, SLPD
Anthony & Bobbi Meloro
Jean-Carl Menelas
Nancy Mertz
Diane Meyers
Charles Michael
Mary Miesmer
Susan Miller
Ashley Mills
Mark Minor
Debbie Mintzer
Ruby Mochidome
Ameet & Sejal Modi
Wes Molenaar
Joyce Monshaugen
Michelle Montgomery
Ray & Susan Mooers
Christine Moore
Edmund Moore
Jim & Jackie Moriarty
The Morrison & Foerster Foundation
Nora Morrison
Teng Moua, MD
Pradipta Muduli
Danny Mufarrige
Jill Murphey
Pamela Muse
Joan Myers
David & Andi Mysza
Giridhar Nallapareddy
Neha
Jon Nelson
Randy & Amy Nelson
Netflix
Mary Neumer
Next Level Performance
Bryan Nichols
Mary Nix
Cecilia Nobel
Nordstrom Employee
Charitable Match Program
Travis Norman
Patrick Nosker
Susan Oakley
Obut Giving Fund
Liam O’Connor
Thomas & Janet O’Connor
Albert Oestriecher
Hilary Olson
Karen Oneill
John O’Neill
Linda Osterman
Duane Oyen
Gretchen Pacoe
Palmyra Fire Company, Inc.
Jorge & Betty Palomo
Paradise Harley-Davidson
Kushal Parbadia
Daniel Park
Atul Patel & Ranjan Patel
The Mehul & Nehal Patel Family
Toby Patel
Kevin Paul
PAVCO, INC.
Ed Pavlish
Elizabeth Payne
PEC United Charities, Inc.
Keith & Lisa Peel
Andre & Michelle Pelletier
Lesley Peng
Matt & Jenny Penniman
Danielle Perez
Anthony & Val Peroni
Letty Perry
Michael & Kathie Phillips
Susan Phillips-Gray
Bruce Pihlstrom
Michael & Laura Pincus
Frederick Pitman
Charles W. Postas, Jr.
Diana Powell
Jennifer Power
Ravindra & Kumkum Prakash
Kempton & Patty Bea Presley
Matthew Price
Richard W. & Ida Price
Private Health
Providence Anesthesiology
Associates
Kelley Pyles
David Quinalty
R. Brown Fund
Kristin Raack
Trisha Radner-Martin
PFF 2025 Donors
Raga Partners
Lorraine Rangel-Brown
Bill Ranik
Karen Rankin
Steve Rasmussen
Connie Raub
Sandhya Ravindranath & Family
James & June Reed
Jim Reeder
Regeneron
Ursula Reikes
Nell Reitinger
Ronald & Mary Retzke
Sarah Rhee
Charlotte Rhoden
Melissa Rhodes
Eileen Richardson
The Ridgeback Group
John Riley
Jack & Laura Risher
Paul Rivera
RiverStone Resources
George Roberta
Law Offices of Brian A. Robillard,
PLLC
Debra Rodkin
Mary Roeder
Dalen Roehm
Jeff & Eva Rose
Kitsy Rose
The Rossiter Family
Skip Rothe
Tom & Eileen Rotkis
Fred Rowe
Robert Rowland
Julia Runyon
Nancy Rutledge
RV Repair Bear & Art
Frank Salisbury
Nancy Sanchez
Vicki Sandburg
Gina Santoro
Tom Saracco & Kathleen Halston
Uma Sartory
Johanna Schaub
Mary Scott
Holly Seace
James Seaton
Lukas Sehlke
Charles & Pam Sehlke
Nathan Serpas
David & Maria Seward
Scott & Caveni Shafranek
Saumil Shah
Anjali Shah
Alison Shepard
Dae Sheridan
Kevin Sherlock
Bruce Sherrill
David Shirley
Luke Sikma
John Silknitter
Tamara Silver
John Silverman
Rachel Silverstein
The Toby & Arun Singhania Family
Lindi Slaughter
Mike & Kellie Slovis
Anne Smith
Marc & May Smith
Solomon Family
Neeraj Soni
Jennifer Stelly
Jerry Stewart
The Stewart Title Foundation, Inc.
Cheryl Stith
Jeffrey Stone
Timothy Stookesberry
Candida Stoutenborough
The Stratton Family
Charitable Fund
Aarti Sura
Carolyn Swanson
The Ryo Takigawa Family
Joanne Taylor
William Warren Taylor
Dominic Testa
Texas Instruments Foundation
Krishna Thavarajah, MD
Randal Thompson
Margaret C. Thorne
Wayne Timberlake
James Tobin
Jessica Tobin
Catherine Todd
Melissa Tokosh
Jean Tong
Dean Topping
Ashley Torres-Gibson
Tracy Family Foundation
PFF 2025 Donors
Kathryn Trebonsky
David Tubman
Charles Tujo
Mary Turner
Marilyn Uffinger Koval
Umami Sushi
Haresh Umaretiya
Izaro Urreiztieta
Vanguard Community Fund
Teresa Vasquez
Denise Vaughn
Dorothy Vernimb
Simon Veronneau
The Villani Family Foundation
Michael & Tammy Vrabel
Billy Walker
Gerry Wallace
JoAnn Wallace
Patrick Wallace
Chris Ward
Stephen H. & Maria A. Ward
Irene Wardzala
Warner Bros. Discovery
Tammy A. Warren
Rebecca Watson
Roberta Bair Watts
John Weathington
Rebecca Weaver
Bruce Weber
Byron Webster
Nicole Welch
Ben & Judy Wells
Joseph Westerhaus
Melissa Wheeler
Lois White
Jessica Whitney
Dave & Mary Ellen Wible
David & Kasia Wible
Shirley Williams
Erin Wilms
Leon Wilson
Patricia Winters
Ben & Katie Wire
Tom & Megan Woitovich
Jim & Janice Wolak
Michael Wolitzer
Jennifer Woo
Terrell Woosley
Donald Wyeth
Alice Wyland
Suzanna Yandell
Paul Yaworsky
Larry & Annette Yeske
Susan Yturraspe
Chohee Yun
Rihan Zalavadia
Bernard & Patricia Zandstra
ZDC Area 6
Haihong Zheng
Shuguang Zhu
Mary Zier
Zoetis
Cynthia Zornes
ZS Associates
THE ALBERT ROSE LEGACY SOCIETY
Adele Blumenkrantz
Cleo Corcoran
Lori Kemper
Jeffrey Merritt
The Estate of Nelly Pease
Trisha Swanson
Patricia Warner
Ron Witmer
223 West Jackson Blvd.
Suite 350, Chicago, Illinois, 60606
Phone: 844.TalkPFF | 844.825.5733
help@pulmonaryfibrosis.org pulmonaryfibrosis.org
OUR MISSION
The Pulmonary Fibrosis Foundation is committed to accelerating research, empowering our community, and transforming care so that everyone with pulmonary fibrosis can live a better life. Our ultimate goal is to find a cure for pulmonary fibrosis.